I would love to know where they are at with the application for the Rare Pediatric Disease Voucher. Can only see this being a catalyst for a SP appreciation in the foreseeable future.
The Chairmans address at the AGM mentioned the overall quality and meaningfulness of the clinical data generated in the Neuren Phase 2 studies will be further corroborated when the Phase 2 pediatric study is accepted for publication in a peer-reviewed journal. The manuscript has been submitted and they are just waiting for acceptance and possible publication dates.
the BIG reversal, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |